United Kingdom · Biotechnology startup

Sixfold Bioscience

Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.

Funding reportedLast round: Grant

BiotechnologyLondon, United Kingdom

What company datasets say Sixfold Bioscience raised

Funding, as reported

Reported in all10.6Min the source's currency
Rounds4
Last roundGrant
Last round dateDec 2021
Investors listed8
Y CombinatorW18

Founders and team

From Sixfold Bioscience's own website: 2 founders, 13 on the team.

Dr Anna Perdrix RosellCO-CEO + Founder
Dr George FootCO-CEO + Founder
  • Dr Tina Caroline FlatauChief Business Officer
  • Dr Søren OttosenVP of Research
  • Dr Lara Francesca ScofanoSenior Scientist II
  • Dr Mike WebbScientific Board - Manufacturing
  • Dr Reeta DaswaniSenior Scientist II
  • Dr Sjef De KimpeScientific Board - Translation
  • Dr Sofia AnagianniSenior Scientist II
  • Dr Vidhi LalchandMachine Learning Research Scientist
  • Michal HandzelOperations Manager
  • Prof Jonathan WattsScientific Board - Therapeutic
  • Prof Neil LawrenceScientific Board - Machine Learning
  • Prof Roger StrömbergScientific Board - Chemistry
  • Sally WernerSenior Scientist II

On 3 portfolio pages

Investors who name them

Each firm lists Sixfold Bioscience on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Sixfold Bioscience in front of investors. Or tell us what we have wrong.

List your startupSend a correction